World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
38
Citations
5117
World Ranking
8935
National Ranking
4738

Adam Bisaga publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Adam Bisaga sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 95 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Adam Bisaga D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Adam Bisaga sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 38 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Adam Bisaga is affiliated with Columbia University in the United States and focuses research efforts primarily within the field of Medicine. Their work spans several subfields including Public Health, Environmental and Occupational Health, Epidemiology, Cellular and Molecular Neuroscience, Psychiatry and Mental Health, and Pharmacology. The research topics they address predominantly relate to Opioid Use Disorder Treatment, Substance Abuse Treatment and Outcomes, Neurotransmitter Receptor Influence on Behavior, Treatment of Major Depression, Attention Deficit Hyperactivity Disorder, Prenatal Substance Exposure Effects, and the intersection of HIV, Drug Use, and Sexual Risk.

Bisaga's publication record features contributions mainly to journals such as Drug and Alcohol Dependence, Addiction, The Canadian Journal of Psychiatry, Journal of Dental Education, and Psychopharmacology. Their notable recent academic papers include:

  • Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis (2020, Psychopharmacology)
  • Quetiapine treatment for cannabis use disorder (2020, Drug and Alcohol Dependence)
  • Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorder (2021, Alcoholism Clinical and Experimental Research)
  • Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum (2020, Advances in Medical Education and Practice)
  • Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk (2023, BMJ Mental Health)

Frequent collaborators in Bisaga's research include Edward V. Nunes, Frances R. Levin, Matisyahu Shulman, Mei-Chen Hu, and Vítor S. Tardelli. Collaboration patterns indicate a concentration on substance use and treatment-related studies.

Their scientific output demonstrates a focus on clinical and translational research related to substance use disorders, pharmacological treatment options, and behavioral health interventions. Bisaga has participated in advancing understanding of medication treatments for stimulant, cannabis, and opioid use disorders, as well as examining attitudes and educational approaches toward substance use disorders among medical students.

Best Publications

  • Cognitive deficits predict low treatment retention in cocaine dependent patients

    Efrat Aharonovich;Deborah S. Hasin;Adam C. Brooks;Xinhua Liu

  • Development of a Cascade of Care for responding to the opioid epidemic

    Arthur Robin Williams;Arthur Robin Williams;Edward V. Nunes;Edward V. Nunes;Adam Bisaga;Adam Bisaga;Frances R. Levin;Frances R. Levin

  • Cerebral glucose metabolism in women with panic disorder

    Adam Bisaga;Jack L. Katz;Angelo Antonini;C. Eugene Wright

  • Developing an opioid use disorder treatment cascade: A review of quality measures.

    Arthur Robin Williams;Edward V. Nunes;Adam Bisaga;Harold A. Pincus

  • The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.

    Adam Bisaga;Sandra D. Comer;Amie S. Ward;Piotr Popik

  • Cognition, commitment language, and behavioral change among cocaine-dependent patients

    Efrat Aharonovich;Paul C. Amrhein;Adam Bisaga;Edward V. Nunes

  • Sex differences and hormonal influences on response to cold pressor pain in humans.

    William J. Kowalczyk;Suzette M. Evans;Adam M. Bisaga;Maria A. Sullivan

  • In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-d-aspartate (NMDA) antagonists

    Adam Bisaga;Piotr Popik

  • Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

    Vitor S Tardelli;Adam Bisaga;Felipe B Arcadepani;Gilberto Gerra

  • Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial ☆

    Frances R. Levin;John J. Mariani;Martina Pavlicova;Daniel Brooks

  • A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.

    Frances R. Levin;John Mariani;Daniel J. Brooks;Martina Pavlicova

  • A randomized placebo-controlled trial of gabapentin for cocaine dependence

    Adam Bisaga;Efrat Aharonovich;Fatima Garawi;Frances R. Levin

  • Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.

    Maria Sullivan;Adam Bisaga;Martina Pavlicova;C. Jean Choi

  • Extended Release Mixed Amphetamine Salts and Topiramate for Cocaine Dependence: A Randomized Controlled Trial

    John J. Mariani;Martina Pavlicova;Adam Bisaga;Edward V. Nunes

  • The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone

    Adam Bisaga;Maria A. Sullivan;Andrew Glass;Kaitlyn Mishlen

  • Interaction between naltrexone and oral THC in heavy marijuana smokers.

    Margaret Haney;Adam Bisaga;Richard W. Foltin

  • Acute interaction of baclofen in combination with alcohol in heavy social drinkers.

    Suzette M. Evans;Adam Bisaga

  • A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.

    Maria A. Sullivan;Adam Bisaga;Martina Pavlicova;Kenneth M. Carpenter

  • Reinstatement of morphine-conditioned reward is blocked by memantine.

    Piotr Popik;Malgorzata Wrobel;Adam Bisaga

  • Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder

    Adam Bisaga;Wojciech Danysz;Richard W. Foltin

Frequent Co-Authors

Edward V. Nunes
Edward V. Nunes Columbia University
Frances R. Levin
Frances R. Levin Columbia University
Sandra D. Comer
Sandra D. Comer Columbia University
Piotr Popik
Piotr Popik Polish Academy of Sciences
Eric J. Rubin
Eric J. Rubin Harvard University
Mark Olfson
Mark Olfson Columbia University
Wojciech Danysz
Wojciech Danysz Merz Pharmaceuticals
Richard W. Foltin
Richard W. Foltin Columbia University
Christina W. Hoven
Christina W. Hoven Columbia University
Margaret Haney
Margaret Haney Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in psychology opens up numerous opportunities, both in traditional and online learning formats. Many students start with a bachelor's degree in psychology before pursuing online master's or doctoral programs. These advanced degrees allow for specialization in clinical counseling, organizational psychology, or mental health therapy.

Becoming a practicing, licensed therapist requires meeting specific state requirements. For example, those interested in practicing in Kentucky should review the Louisville licensed therapist requirements. Similarly, potential counselors planning to work in Texas can find details about becoming a licensed therapist in Lubbock.

Licensing requirements vary by location—candidates in Wisconsin should review the licensed therapist requirements in Madison, while those aiming to practice in Tennessee can refer to guidelines on how to become a licensed therapist in Memphis.

Ultimately, earning an online degree can provide flexibility, but aspiring therapists must ensure their program meets the state's licensure requirements for the region where they plan to practice.

Best Scientists Citing Adam Bisaga

Trending Scientists

Recently Published Articles